Search Results
263 results found for "Western lifestyle diseases"
Posts (189)
- Design and validation of recombinant protein standards for quantitative Western blot analysis of...
October 2022 Design and validation of recombinant protein standards for quantitative Western blot analysis CB1 receptor C-terminal tail for use as standard and negative control, respectively, in quantitative Western Estimated values of CB1 receptor density obtained by quantitative Western blot were of the same order
- Adenosine receptor signalling in Alzheimer's disease
October 2022 "Alzheimer's disease (AD) is the most common dementia in the elderly and its increasing Despite a better understanding of the disease, the current mainstay of treatment cannot modify pathogenesis suggests adenosine G protein-coupled receptors (GPCRs) are promising therapeutic targets for Alzheimer's disease In this review, we provide an accessible summary of the literature on Alzheimer's disease and the therapeutic
- Adenosine receptor signalling in Alzheimer's disease
August 2022 "Alzheimer's disease (AD) is the most common dementia in the elderly and its increasing prevalence Despite a better understanding of the disease, the current mainstay of treatment cannot modify pathogenesis suggests adenosine G protein-coupled receptors (GPCRs) are promising therapeutic targets for Alzheimer's disease In this review, we provide an accessible summary of the literature on Alzheimer's disease and the therapeutic
Other Pages (74)
- Pharmacological and Genetic Preclinical Models of Ghrelin Receptor Functional Selectivity to Investigate Metabolic Disease Pathophysiology
and Genetic Preclinical Models of Ghrelin Receptor Functional Selectivity to Investigate Metabolic Disease GPCR biased signaling to design/develop new pharmacotherapeutics to treat reward- and metabolism-based diseases reward and its downstream dysregulation of metabolic function, particularly in response to obesogenic 'Western novel GPCR pharmacotherapies that improve efficacy and minimize side effects for diet-induced metabolic diseases
- Ep 31 with Dr. Kevin Pfleger
Kevin is also Director, Biomedical Innovation at The University of Western Australia (UWA) and the MTPConnect Western Australian Life Sciences Innovation Hub. Kevin Pfleger on the web LinkedIn ResearchGate Pubmed Google Scholar University of Western Australia
- Interaction with the cell adhesion molecule NEGR1 affects mGluR5 cell signalling
Ph.D. from UFMG in 2006 and, after that, she performed her postdoctorate studies at the University of Western were shown to be very effective to rescue the cell death observed in a mouse model of Huntington’s disease